previously number of years, the UK has witnessed a revolution in clinical pounds‑loss solutions — with the introduction of semaglutide (Wegovy®) towards the rising acceptance of tirzepatide (Mounjaro®). Now, another name is drawing attention in both medical and public wellness circles: Retatrutide. Currently under enhancement by Eli Lilly an